Tokyo, Jan. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060348) titled 'A Study to Observe Changes in Liver Function and Gut Microbiota in Patients with Fatty Liver Disease and High Triglycerides Receiving Pemafibrate' on Jan. 14.
Study Type:
Observational
Primary Sponsor:
Institute - Ehime University
Condition:
Condition - Metabolic Dysfunction Associated Steatotic Liver Disease and Hypertriglyceridemia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate longitudinal changes in liver function-related clinical parameters in patients with MASLD complicated by hypertriglyceridemia who are treated with pemafibrate
Basic object...